Prescribing patterns and clinical outcomes of biological disease-modifying anti-rheumatic drugs for rheumatoid arthritis in Spain.
CONCLUSIONS: Prescribing pattern analysis showed the highest responses and remission rates with tocilizumab and TNF-α inhibitors. The main reasons for withdrawal were lack of response and adverse effects. Further research is needed to improve pharmacological RA management in real-life settings.
PMID: 32767346 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
More News: Actemra | Arthritis | Drugs & Pharmacology | Enbrel | Remicade | Rheumatoid Arthritis | Rheumatology | Rituxan | Spain Health | Study | Teaching | Teaching Hospitals | Universities & Medical Training